Concepedia

Gary R. Fanger

GR

40

Publications

3.9K

Citations

30

H-Index

1991

Active since

Affiliations

Corixa Corporation(Current)

University of Colorado Denver

National Jewish Health

University of Massachusetts Chan Medical School

Dartmouth College

Gary R. Fanger is an author at Corixa Corporation specializing in medicine, pathology, and cell biology.

Top concepts

MedicinePathologyCell BiologyTumor BiologyCancer ResearchCell SignalingSignal TransductionOncologyMolecular DiagnosticsImmunology

Publications per year

1991–2021

40

Publications

40

P504S

Zhong Jiang, Bruce A. Woda, Kenneth L. Rock et al. · The American Journal of Surgical Pathology · 2001 · 364 citations

Tumor Biology, Urology, Prostate Carcinoma +12

<i>Enterococcus</i> peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy

Matthew E. Griffin, Juliel Espinosa, Jessica L. Becker et al. · Science · 2021 · 324 citations · Full text

MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42

Gary R. Fanger · The EMBO Journal · 1997 · 298 citations · Full text

Signal Transduction, Signaling Pathway, Cell Regulation +9

MEK kinase 1 gene disruption alters cell migration and c-Jun NH <sub>2</sub> -terminal kinase regulation but does not cause a measurable defect in NF-κB activation

Toshiaki Yujiri, Margaret F. Ware, Christian Widmann et al. · Proceedings of the National Academy of Sciences · 2000 · 240 citations

Expression of α-methylacyl-coa racemase (p504s) in various malignant neoplasms and normal tissues: a study of 761 cases

Zhong Jiang, Gary R. Fanger, Bruce A. Woda et al. · Human Pathology · 2003 · 200 citations

Tumor Biology, Normal Tissues, Tumoral Pathology +12

Rows per page

1–5 of 40